H|T: The Healthtech Times – BC’s Kardium secures $143M CAD for heart treatment
Plus: Telehealth execs charged with fraud.
Plus: Telehealth execs charged with fraud.
The deals, if successful, will have a combined value of over $36 million.
Each startup is receiving between $150,000 to $500,000 based on company stage, needs, and evaluation processes.
Heylist, Vosyn, Pok Pok, and Ability Biologics have all raised fresh capital.
Plus: Feds table bill with new healthtech data security rules.
The financing follows Kardium’s $158-million CAD round in 2021.
Plus: The new Alberta program looking to connect the healthtech ecosystem.
GreenSky-backed University of Toronto spinout has set its initial sights on dentistry.
Valsoft closed $229 million CAD in growth financing in January to expand its portfolio.
Biotech startup aims to unlock hair regrowth, skin rejuvenation, disease treatment by preserving cells.
After finding product-market fit, Ginger Desk aims to build the platform it needs to scale.
Plus: Once worth $2.3B, COVID-19 test maker Cue Health shutters.
IDEATE is being supported by a $2.1-million investment from PrairiesCan.
The startup is looking to expand across Canada and the United States starting later this year.
Clarius’ handheld device will be used to support the early detection of psoriatic arthritis.